SCHEMBL7719152

SCHEMBL7719152

Fc1ccc(N2CCN([C@H]3C[C@H]4C[C@@H](N5CCN(c6ccc(F)cc6)CC5)C[C@H]4C3)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.53
▸ MAPT P10636 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ GFER P55789 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ DRD2 P14416 1/20 0.48
▸ ADRA1D P25100 1/20 0.48
▸ ADRA1A P35348 1/20 0.48
▸ ADRA1B P35368 1/20 0.48
▸ POLB P06746 1/20 0.46
▸ DPP4 P27487 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7716949 0.87 MEN1 (0.52) ALDH1A1MAPTLMNAMAPK1HTT
SCHEMBL8230863 0.80 ALDH1A1 (0.52) ALDH1A1MAPTLMNAMAPK1HTT
SCHEMBL22848339 0.80 L3MBTL3 (0.56) ALDH1A1MAPTLMNAMAPK1HTT
SCHEMBL10373626 0.79 MAPT (0.77) ALDH1A1MAPTLMNAMAPK1HTT
SCHEMBL7605419 0.78 POLB (0.54) ALDH1A1MAPTLMNAMAPK1HTT
SCHEMBL13698426 0.77 ALDH1A1 (0.54) ALDH1A1MAPTLMNAMAPK1HTT
SCHEMBL22175018 0.77 KMT2A (0.62) ALDH1A1MAPTLMNAMAPK1HTT
SCHEMBL22570271 0.77 ALDH1A1 (0.53) ALDH1A1MAPTLMNAMAPK1HTT
SCHEMBL24619071 0.77 OPRL1 (0.49) ALDH1A1MAPTLMNAMAPK1HTT
SCHEMBL22570043 0.75 KMT2A (0.66) ALDH1A1MAPTLMNAMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372762-B1 HETEROCYCLIC COMPOUNDS FOR NERVOUS SYSTEM DISORDERS PFIZER INC. 2002-04-16 — — US disclosed
EP-0953567-A2 Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity Pfizer Products Inc. (US) 1999-11-03 — — EP disclosed
Send feedback